FI121273B - FAS/APO1-reseptorien toiminnan modulaattorit - Google Patents
FAS/APO1-reseptorien toiminnan modulaattorit Download PDFInfo
- Publication number
- FI121273B FI121273B FI972457A FI972457A FI121273B FI 121273 B FI121273 B FI 121273B FI 972457 A FI972457 A FI 972457A FI 972457 A FI972457 A FI 972457A FI 121273 B FI121273 B FI 121273B
- Authority
- FI
- Finland
- Prior art keywords
- protein
- fas
- mort
- cells
- sequence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
- C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
- C12N9/641—Cysteine endopeptidases (3.4.22)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6472—Cysteine endopeptidases (3.4.22)
- C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Transmitters (AREA)
- Peptides Or Proteins (AREA)
- Optical Communication System (AREA)
- Radar Systems Or Details Thereof (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL11200294 | 1994-12-15 | ||
IL11200294A IL112002A0 (en) | 1994-05-11 | 1994-12-15 | Modulatiors of tnf/ngf superfamily receptors, their preparation and use |
IL112692A IL112692A (en) | 1995-02-19 | 1995-02-19 | ANTIBODIES TO PROTEIN WHICH BINDS TO Fas-R |
IL11269295 | 1995-02-19 | ||
IL11461595A IL114615A0 (en) | 1995-07-16 | 1995-07-16 | Modulators of the function of fas receptors and other proteins |
IL11461595 | 1995-07-16 | ||
US9516542 | 1995-12-14 | ||
PCT/US1995/016542 WO1996018641A1 (en) | 1994-12-15 | 1995-12-14 | Modulators of the function of fas/apo1 receptors |
Publications (3)
Publication Number | Publication Date |
---|---|
FI972457A0 FI972457A0 (fi) | 1997-06-10 |
FI972457A FI972457A (fi) | 1997-06-10 |
FI121273B true FI121273B (fi) | 2010-09-15 |
Family
ID=27271687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI972457A FI121273B (fi) | 1994-12-15 | 1997-06-10 | FAS/APO1-reseptorien toiminnan modulaattorit |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0871645B1 (ja) |
JP (1) | JP3787355B2 (ja) |
KR (1) | KR100536394B1 (ja) |
CN (1) | CN1105725C (ja) |
AT (1) | ATE377073T1 (ja) |
AU (1) | AU706401B2 (ja) |
CA (1) | CA2207815C (ja) |
CY (1) | CY2586B2 (ja) |
DE (1) | DE69535634T2 (ja) |
DK (1) | DK0871645T3 (ja) |
ES (1) | ES2292172T3 (ja) |
FI (1) | FI121273B (ja) |
HK (1) | HK1007248A1 (ja) |
MX (1) | MX9704501A (ja) |
NO (1) | NO324725B1 (ja) |
PT (1) | PT871645E (ja) |
UA (1) | UA58489C2 (ja) |
WO (1) | WO1996018641A1 (ja) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL114615A0 (en) * | 1995-07-16 | 1995-11-27 | Yeda Res & Dev | Modulators of the function of fas receptors and other proteins |
US6060238A (en) * | 1995-02-13 | 2000-05-09 | The Regents Of The University Of Michigan | Method and composition for regulating apoptosis |
US6015665A (en) * | 1995-02-13 | 2000-01-18 | The Regents Of The University Of Michigan | Method and composition for regulating apoptosis |
US7097972B1 (en) | 1995-02-13 | 2006-08-29 | Regents Of The University Of Michigan | Method and composition for regulating apoptosis |
AU755662B2 (en) * | 1995-02-22 | 2002-12-19 | Yeda Research And Development Co. Ltd. | Modulators of regulatory proteins |
ES2242195T3 (es) * | 1995-02-22 | 2005-11-01 | YEDA RESEARCH & DEVELOPMENT COMPANY, LTD. | Moduladores de proteinas reguladoras. |
US7807783B1 (en) | 1995-04-03 | 2010-10-05 | The Regents Of The University Of Michigan | Methods and compositions for regulating FAS-associated apoptosis |
US6747138B1 (en) | 1995-04-03 | 2004-06-08 | Regents Of The University Of Michigan | Methods and compositions for regulating Fas-associated apoptosis |
US6399327B1 (en) | 1995-07-16 | 2002-06-04 | Yeda Research And Development Co. Ltd. | Modulators of the function of FAS receptors and other proteins |
US6911526B2 (en) * | 1996-07-22 | 2005-06-28 | The Trustees Of Columbia University In The City Of New York | Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof |
EP0842665A3 (en) * | 1996-11-14 | 2002-12-18 | Smithkline Beecham Corporation | Interleukin-1 beta converting enzyme like apoptotic proteases and their agonists |
US5969102A (en) * | 1997-03-03 | 1999-10-19 | St. Jude Children's Research Hospital | Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof |
AU6969998A (en) * | 1997-04-25 | 1998-11-24 | American Home Products Corporation | Neuronal mort1 isoforms |
AU7988698A (en) * | 1997-06-26 | 1999-01-19 | Chiron Corporation | Human fadd-interacting protein (fip) |
US7833529B1 (en) | 1999-01-07 | 2010-11-16 | Zymogenetics, Inc. | Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor |
US6015712A (en) * | 1999-07-19 | 2000-01-18 | Isis Pharmaceuticals Inc. | Antisense modulation of FADD expression |
DK1436003T3 (da) | 2001-05-24 | 2010-03-15 | Zymogenetics Inc | TACI-immunoglobulin-fusionsproteiner |
US6743630B2 (en) | 2002-03-06 | 2004-06-01 | The Trustees Of Columbia University In The City Of New York | Method of preparing a protein array based on biochemical protein-protein interaction |
CA2618763A1 (en) | 2005-08-09 | 2007-02-15 | Zymogenetics, Inc. | Methods for the treatment and prevention of abnormal cell proliferation using taci-fusion molecules |
AR059945A1 (es) | 2005-08-09 | 2008-05-14 | Zymogenetics Inc | Metodos para tratar afecciones malignas de celulas b que utilizan una molecula de fusion taci-ig |
NZ572373A (en) | 2006-05-15 | 2012-02-24 | Ares Trading Sa | Methods for treating rheumatoid arthritis using a taci-ig fusion molecule |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO178777C (no) * | 1994-05-09 | 1996-05-29 | Kvaerner Eng | Varmeveksler |
US7807783B1 (en) * | 1995-04-03 | 2010-10-05 | The Regents Of The University Of Michigan | Methods and compositions for regulating FAS-associated apoptosis |
US5674734A (en) * | 1995-05-18 | 1997-10-07 | President And Fellows Of Harvard College | Cell death protein |
-
1995
- 1995-12-14 CN CN95196789A patent/CN1105725C/zh not_active Expired - Lifetime
- 1995-12-14 UA UA97063391A patent/UA58489C2/uk unknown
- 1995-12-14 PT PT95944148T patent/PT871645E/pt unknown
- 1995-12-14 DK DK95944148T patent/DK0871645T3/da active
- 1995-12-14 AT AT95944148T patent/ATE377073T1/de active
- 1995-12-14 MX MX9704501A patent/MX9704501A/es active IP Right Grant
- 1995-12-14 EP EP95944148A patent/EP0871645B1/en not_active Expired - Lifetime
- 1995-12-14 AU AU46022/96A patent/AU706401B2/en not_active Expired
- 1995-12-14 DE DE69535634T patent/DE69535634T2/de not_active Expired - Lifetime
- 1995-12-14 JP JP51932496A patent/JP3787355B2/ja not_active Expired - Lifetime
- 1995-12-14 CA CA2207815A patent/CA2207815C/en not_active Expired - Lifetime
- 1995-12-14 KR KR1019970703992A patent/KR100536394B1/ko not_active IP Right Cessation
- 1995-12-14 ES ES95944148T patent/ES2292172T3/es not_active Expired - Lifetime
- 1995-12-14 WO PCT/US1995/016542 patent/WO1996018641A1/en active IP Right Grant
-
1997
- 1997-06-10 FI FI972457A patent/FI121273B/fi not_active IP Right Cessation
- 1997-06-12 NO NO19972716A patent/NO324725B1/no not_active IP Right Cessation
-
1998
- 1998-06-24 HK HK98106458A patent/HK1007248A1/xx not_active IP Right Cessation
-
2007
- 2007-11-20 CY CY0700017A patent/CY2586B2/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2207815A1 (en) | 1996-06-20 |
NO972716D0 (no) | 1997-06-12 |
FI972457A0 (fi) | 1997-06-10 |
FI972457A (fi) | 1997-06-10 |
KR100536394B1 (ko) | 2006-04-21 |
HK1007248A1 (en) | 1999-04-09 |
ES2292172T3 (es) | 2008-03-01 |
PT871645E (pt) | 2007-11-14 |
AU706401B2 (en) | 1999-06-17 |
MX9704501A (es) | 1997-10-31 |
ATE377073T1 (de) | 2007-11-15 |
DE69535634D1 (de) | 2007-12-13 |
EP0871645B1 (en) | 2007-10-31 |
CY2586B2 (en) | 2009-11-04 |
NO972716L (no) | 1997-07-11 |
CN1105725C (zh) | 2003-04-16 |
DK0871645T3 (da) | 2007-12-03 |
WO1996018641A1 (en) | 1996-06-20 |
AU4602296A (en) | 1996-07-03 |
EP0871645A1 (en) | 1998-10-21 |
CA2207815C (en) | 2011-03-29 |
EP0871645A4 (en) | 1999-11-24 |
CN1169729A (zh) | 1998-01-07 |
UA58489C2 (uk) | 2003-08-15 |
JP3787355B2 (ja) | 2006-06-21 |
DE69535634T2 (de) | 2008-08-28 |
JPH10510712A (ja) | 1998-10-20 |
NO324725B1 (no) | 2007-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI121273B (fi) | FAS/APO1-reseptorien toiminnan modulaattorit | |
US8236507B2 (en) | Modulators of TNF receptor associated factor (TRAF), their preparation and use | |
JP3980641B2 (ja) | Fas受容体およびほかのタンパク質の機能のモジュレーター | |
US20070166787A1 (en) | Modulators of regulatory proteins | |
WO1996018641A9 (en) | Modulators of the function of fas/apo1 receptors | |
EP0813419B1 (en) | Modulators of regulatory proteins | |
IL109632A (en) | Modulators of the function of tnf receptors | |
JP4351389B2 (ja) | Tnf/ngfレセプターファミリーおよびほかのタンパク質のレセプター機能調節物質 | |
US7323548B2 (en) | Modulators of the function of FAS/APO1 receptors | |
RU2241747C2 (ru) | Молекула днк, кодирующая полипептид, способный связываться с внутриклеточным доменом рецептора лиганда fas(fas-ic), полипептид, способ его получения, вектор, способ модуляции действия лиганда fas-r на клетки (варианты), фармацевтическая композиция (варианты), спрособ выделения и идентификации белка | |
US7108999B1 (en) | Modulators of the function of FAS/AP01 receptors | |
AU767967B2 (en) | Modulators of TNF receptor associated factor (TRAF), their preparation and use | |
RU2235779C2 (ru) | Последовательность днк, кодирующая полипептид, который связывается с mort-1 (варианты), полипептид (варианты) и способ его получения, вектор, способ модулирования действия лиганда fas-r или tnf на клетки (варианты), способ обработки клеток, способ выделения и идентификации белков, способ модулирования индуцируемого mort-1 действия или индуцируемого mort-1 связывающим белком действия на клетки | |
JP2009148285A (ja) | Tnf/ngfレセプターファミリーおよびほかのタンパク質のレセプター機能調節物質 | |
IL112692A (en) | ANTIBODIES TO PROTEIN WHICH BINDS TO Fas-R | |
IL126428A (en) | Modulators of tnf receptor associated factor (traf), their preparation and use | |
AU5834599A (en) | Modulators of regulatory proteins | |
CZ314699A3 (cs) | Sekvence DNA, vektor a protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 121273 Country of ref document: FI |
|
MA | Patent expired |